AstraZeneca to invest Rs 250 crore in expanding its GITC in Chennai

This will be the company's largest GCC in the world. This is a monumental addition by the company, joining other global giants like Hitachi Energy in establishing their biggest GCCs in Chennai

AstraZeneca
Photo: Bloomberg
Shine Jacob Chennai
1 min read Last Updated : Jul 04 2024 | 5:52 PM IST
AstraZeneca India (AZIPL), the global capability centre (GCC) of the pharma major AstraZeneca, said on Thursday that the company will invest Rs 250 crore in expanding its Global Innovation and Technology Centre (GITC) in Chennai.

This will be the company's largest GCC in the world. This is a monumental addition by the company, joining other global giants like Hitachi Energy in establishing their biggest GCCs in Chennai.
"This new campus will be home to 4,000 high-quality jobs in Chennai, and we are thrilled to see AstraZeneca expanding their existing capacity with talent sourced from the huge talent pool available in Tamil Nadu! Their decision to reinvest and grow in Tamil Nadu is a powerful endorsement of our state—our people, our talent, and our policies," said TRB Rajaa, state industries minister.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :AstraZenecaAstraPharma CompaniesIndian pharma companiesIndian investments into GCCChennai

First Published: Jul 04 2024 | 5:38 PM IST

Next Story